Quantcast

Latest metronidazole Stories

2014-07-15 08:28:50

TORONTO, July 15, 2014 /CNW/ - The Odette Cancer Centre at Sunnybrook Health Sciences Centre in conjunction with Galderma Canada are pleased to announce that Metvix PDT (Photodynamic Therapy), is now available at the Odette Cancer Centre in Toronto as an additional treatment option for patients with NMSC (non-melanoma skin cancer). For eligible patients the positive impact of Metvix PDT cannot be overestimated in pre-cancerous AK (Actinic Keratoses) and superficial BCC (Basal Cell...

2014-07-10 12:30:26

Expansion Completes Galderma's Global Skin Health Footprint FORT WORTH, Texas, July 10, 2014 /PRNewswire/ -- Galderma S.A. (Galderma) announced that it has gained full rights to distribute Restylane®, Perlane®, Emervel®, Sculptra® and Dysport® from Valeant Pharmaceuticals International, Inc. The expansion into aesthetic and corrective dermatology in the U.S. and Canada completes Galderma's global skin health footprint and extends its leadership in aesthetic medicine worldwide....

2014-03-25 16:26:26

DUBLIN and LAVAL, Quebec, March 25, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Metronidazole 1.3% Vaginal Gel, an antibiotic for the treatment of bacterial vaginosis (BV). Actavis acquired the rights to Metronidazole 1.3% from Valeant Pharmaceuticals International in April 2013. Bacterial vaginosis...

2014-02-26 00:22:23

LAUSANNE, Switzerland, February 26, 2014 /PRNewswire/ -- - Galderma portfolio expands to offer a fast onset and long-acting alpha-2 adrenergic receptor agonist - Galderma, a leading global pharmaceutical company exclusively focused on dermatology, today announced that the European Commission has granted Marketing Authorisation in Europe for Mirvaso(R) (brimonidine) 3 mg/g gel. To view the Multimedia News Release, please...

2014-01-08 12:30:22

LAUSANNE, Switzerland, Jan. 8, 2014 /PRNewswire/ -- Galderma S.A. announced today that the Nomination and Compensation Committee of Galderma Pharma S.A. appointed industry veteran Stuart Raetzman to Chief Executive Officer of Galderma Laboratories, L.P. and Vice President North America, effective March 1, 2014. Raetzman was also elected to the company's Global Executive Committee. Raetzman will report directly to Humberto C. Antunes, President and CEO of Galderma S.A. Stuart Raetzman...

New Compounds Could Have Major Impact In Struggle Against Evolving Drug Resistance
2013-10-07 16:03:42

University of California - San Diego By tinkering with their chemical structures, researchers at the University of California, San Diego School of Medicine have essentially re-invented a class of popular antimicrobial drugs, restoring and in some cases, expanding or improving, their effectiveness against drug-resistant pathogens in animal models. Writing in the October 7 Early Edition of PNAS, Lars Eckmann, MD, professor of medicine, and colleagues describe creating more than 650 new...

2013-08-01 23:24:42

According to Dr. Joshua Fox, estimates for the total number of rosacea sufferers in the United States vary from 14 to 16 million. Many who suffer from the disease don’t understand rosacea symptoms and treatment options available for them. Roslyn, NY (PRWEB) August 01, 2013 Red splotches, facial flushing, unsightly bumps and pimples, bloodshot, watery eyes and even swelling of the nose are all symptoms which often fall under a general diagnosis of rosacea. But how is it possible to know...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.